POGO

  • Staff List
  • Contact Us

Main menu

Skip to primary content
Skip to secondary content
  • About Us
    • Diversity, Equity, Inclusion
    • Childhood Cancer Care Plan
    • Our Mission and Vision
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • Reports
    • Newsroom
    • Job Opportunities
    • Accessibility
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO Multidisciplinary Symposium on Childhood Cancer
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • POGO Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

Blog

POGO > Blog > consent
[sharethis]

Tag: consent

2018 POGO Symposium on Childhood Cancer

Posted on November 22, 2018 by Jamie Irvine

The 2018 POGO Multi-Disciplinary Symposium on Childhood Cancer – Precision Medicine in Pediatric Oncology – examined clinical and scientific advances in precision medicine and explored how those advances are impacting the diagnosis and treatment of cancer in children.

Over 250 delegates representing a variety of disciplines attended the conference.

VIEW THE PROGRAM

Click on the session titles below to view presentations that POGO has permission to share. 

PLENARY SESSIONS

Precision Medicine in the Pediatric Oncology Clinic: From Feasibility to Clinical Impact
Katherine Janeway, MDMD, MMSc

Precision Medicine – A Paradigm Shift?
Ian F. Tannock, CM, MD, PhD, DSc
Uri Tabori, MD

Thinking Practically: Delivery of Care Considerations for New Agents
Karen Fung, MSW, RSW
Tara McKeown, RN MN NP-Paediatrics

Ethics and Consent in the Age of Precision Medicine – Forging a Path Forward
Steven Joffe, MD, MPH

Select Poster Presentations
Alexandra Zorzi, MD, FRCPC
Andrew Shuen, PhD Candidate, MD, FRCPC
Lauren Mulrooney, Nursing Student (3rd year)
Valli Subasri, MSc candidate (Medical Biophysics)
Nicole Espinosa, BScH Candidate (Life Sciences)
Mohammad R. Alqudimat, PhD Student (Nursing)
Marta Wilejto, Assistant Professor Paediatric Hematology/Oncology
Sarah Naraine, Fourth Year Nursing Student
Ceilidh Eaton Russell, PhD
Jill Furzer, PhD candidate (health economics)

Targeted and Traditional Agents: Can We Reduce Side Effects Using Pharmacogenomic and Endogenous Biomarkers?
Richard B. Kim, MD, FRCPC

The Future of Immunotherapy, CAR-T and Beyond
Shannon L. Maude, MD, PhD

WORKSHOPS

The Evolution of Clinical Trials in Canada
Rebecca Deyell, MD, MSc, FRCPC
Josh Silvertown, PhD, MBA, MSM
Patrick Sullivan

PROFYLE/KiCS: The ABCs of Precision Medicine in Canada
Alexandra Zorzi, MD
Anita Villani, MD, MSc, FRCPC
Andrea Cote, RN, BScN

CAR-T Cell Therapy in Ontario: Opportunities and Challenges
Joerg Krueger, MD
Stacey Marjerrison, MD, MSc, FRCPC
Colleen Callahan, RN, MSN, CRN

Posted in 2018 Symposium, Education for Health Professionals | Tagged 2018 symposium, CAR-T, Clinical Trials, consent, diagnos, ethics, genetics, pharmacology, precision therapy, psychosocial, side effects

Workshop C – Canada on Capacity: Legal and Ethical Implications

Posted on November 6, 2015 by admin

VIEW THE CASE STUDY

VIEW THE PRESENTATION

Handout: The Capacity to Consent to Treatment in Youth: A Retrospective Lens

Handout: A Guide for Health Care Practitioners in the Assessment of Young People’s Capacity to Consent to Treatment

Presentation Description: 
Young people who are facing the challenges of coping with cancer are faced with many decisions about their treatment options.  Age is not a factor in the determination of a young person’s capacity to consent to treatment.  Capacity to consent to treatment is presumed without consideration of age. The assessment of whether these young people understand the information necessary to make a treatment decision, appreciate the consequences of that decision and are able to communicate that decision, can be challenging for health care practitioners.  The workshop included discussion of some of the factors that need to be considered by the health care practitioner when asked to provide an assessment of the capacity of a youth to whom treatment for cancer is being proposed by the health care provider.

Speakers:
Rose Geist, BSc., MD, FRCPC
Chief and Medical Director, Mental Health Program
Trillium Health Partners; University of Toronto
Medical Psychiatrist, Hospital for Sick Children

Stephen Goudge, Q.C.
Counsel, Paliare Roland Rosenberg Rothstein LLP, Toronto
Board of Directors President, Pediatric Oncology Group of Ontario (POGO)

Lawrence F. Jardine, MD, FRCPC
Section Head, Pediatric Hematology Oncology
Children’s Hospital, London Health Sciences Centre

Posted in 2015 Symposium | Tagged 2015 Symposium, capacity, consent

Workshop B – Defining Capacity: When a Patient Refuses Life-Saving Treatment

Posted on January 2, 2015 by admin

Presentation Description:
It is the duty of all healthcare providers to offer the best available treatment for the best possible outcome. So what is the path forward when a patient refuses this treatment? Structured around three hypothetical pediatric lymphoma cases, this session unraveled the many issues related to defining and determining capacity when a child or adolescent refuses life-saving treatment. 

Speakers (in presentation order):

Donna Johnston, MD, FRCPC, FAAP
Chief, Division of Hematology/Oncology, Children’s Hospital of Eastern Ontario
Associate Professor, University of Ottawa

Rose Geist , MD, FRCPC
MMUS Program Chief and Program Medical Director, Mental Health Program, Trillium Health Partners
Medical Psychiatrist, Department of Psychiatry, Hospital for Sick Children, Toronto

Hon. Stephen Goudge, QC
Counsel, Paliare Roland Rosenberg Rothstein LLP, Toronto

 

 

Posted in 2014 Symposium, Education for Health Professionals | Tagged 2014 Symposium, bioethics, capacity, consent, end of life care, lymphoma

Donate

Blog

Education Portal
Survivor Conference
All Categories

Categories

Newsletter Sign-Up

Please leave this field empty

@POGO4Kids

December 1, 2021

New study published in @CMAJ including @pogo4kids data for Ontario found no significant change in new cancer diagnoses or severity of disease in Canadian children during the first 9 months of the COVID-19 pandemic. https://www.cmaj.ca/content/193/47/E1798

Reply on Twitter 1466130369317679108Retweet on Twitter 14661303693176791087Like on Twitter 146613036931767910813

Follow @POGO4Kids

Quick Links

  • For Professionals
    • Read Cancer Care Plan
    • Review our Guidelines
    • Request Research Data
  • Families & Kids
    • Get POGO AfterCare
    • Meet with a POGO Nurse
    • Get Care Closer to Home
  • For Survivors
    • Find Local Resources
    • Set Goals for your Future
    • Educate Yourself
  • Get Involved
    • Host an Event for POGO
    • Volunteer with POGO
    • Partner with POGO
  • About Us
    • Diversity, Equity, Inclusion
    • Childhood Cancer Care Plan
    • Our Mission and Vision
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • Reports
    • Newsroom
    • Job Opportunities
    • Accessibility
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO Multidisciplinary Symposium on Childhood Cancer
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • POGO Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

©2021 Pediatric Oncology Group of Ontario

480 University Avenue, Suite 1014 | Toronto, Ontario, M5G 1V2, Canada | Charitable Registration Number: 871067245RR0001 |
1-855-FOR POGO (367-7646) | Contact Us | Website Privacy Policy | Website Disclaimer | Satellite Manual Disclaimer |